Mark your calendars for Thursday 24th October 2024, as ResMed (NYSE: RMD) will be revealing its first quarter financial results. This highly awaited announcement is scheduled to take place after market close, pave the way to review a period of expectation and anticipation.
In accordance with the predictions of financial analysts on Wall Street, the firm is on track to report an expected per share of $2.04 profit for the quarter. Furthermore, the firm is projected to disclose a total revenue of $1.18 billion for this quarter.
The earnings report for the corresponding quarter of the prior year unveiled a per-share income of $1.64. This was a direct result of the company's total revenue, which amounted to an impressive $1.1 billion during that specific period.
Financial analysts have shared their forecasts for the company's annual performance, indicating their belief that the company will achieve a total revenue of $5.04 billion. Additionally, they predict that the earnings per share for the company will hit profit of $9.11 by the end of the fiscal year.
Additionally, The company will host a conference call with investors and analysts on 24th October 2024 at 04:30 PM eastern time to review the Q1 2025 financial results.
ResMed (RMD) shares traded as low as $237.63 and as high as $241.17 on a day volume of 614.60 thousand shares, closed Tuesday's regular trading session at $239.98, drop of 0.03 percent.
